![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 03, 2020 2:34:52 AM
To add more to your last post..
The talk about a vaccine taking away Ifenprodil's opportunity should also include the long term applications.
Ifenprodil, should it perform well against COVID-19, will have shown effectiveness against 2 viruses that attack the lungs.
The outlook on a future avian-born virus will not look as bleak with Ifenprodil.
Also... While I know you have clearly stated.. long gone after PhaseII data, I'm looking forward to more focus on the rest of the pipeline in Algernon's arsenal.
At least leave a few (hopefully) freebies.
LS5
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM